Antonio Gualberto
2019
In 2019, Antonio Gualberto earned a total compensation of $2.1M as Former Head of Development and Chief Medical Officer at Kura Oncology, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $125,906 |
|---|---|
| Option Awards | $1,481,424 |
| Salary | $431,000 |
| Other | $11,863 |
| Total | $2,050,193 |
Gualberto received $1.5M in option awards, accounting for 72% of the total pay in 2019.
Gualberto also received $125.9K in non-equity incentive plan, $431K in salary and $11.9K in other compensation.
Rankings
In 2019, Antonio Gualberto's compensation ranked 5,800th out of 13,971 executives tracked by ExecPay. In other words, Gualberto earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,800 out of 13,971 | 59th |
Division Manufacturing | 2,173 out of 5,701 | 62nd |
Major group Chemicals And Allied Products | 782 out of 2,200 | 65th |
Industry group Drugs | 658 out of 1,886 | 65th |
Industry Pharmaceutical Preparations | 484 out of 1,398 | 65th |
Source: SEC filing on April 28, 2020.
Gualberto's colleagues
We found five more compensation records of executives who worked with Antonio Gualberto at Kura Oncology in 2019.